Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

Wednesday, 8 May 2024 (2 weeks ago)
UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped manufacturing Covishield in Dec 2021 due to a fall in demand as well as the emergence of new variants. Covishield accounted for nearly 80% of Covid-19 vaccine doses administered in India.

👓 View full article

0 shares	Share Tweet Save Post Send

💡 newsR Knowledge: Other News Mentions

AstraZeneca British pharmaceutical company

1 in 3 Covaxin recipients hit by adverse events: Study

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..
IndiaTimes 3 days ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Credit: FRANCE 24 English Duration: 01:37Published on January 1, 1970

AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]

AstraZeneca requests European authorisation of Covid vaccine be pulled

AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.

Credit: euronews (in English) Duration: 00:35Published on January 1, 1970

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering it unusable. This decision marks a significant development in the global vaccination effort against Covid-19. #COVID19 #Astrazeneca #COVIDVaccine #Covishield #Worldnews #Indianews #UKCourt #Oneindia #Oneindianews ~PR.320~ED.102~

Credit: Oneindia Duration: 05:11Published on January 1, 1970

Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP [Video]

Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP

Watch as Akhilesh Yadav addresses the crowd in Mainpuri, Uttar Pradesh, discussing key issues including unemployment, Covishield vaccination, and the call to end 'Agniveer'. He also highlights Samajwadi Party's preparations in Kannauj and expresses confidence in SP's victory over BJP in the upcoming Lok Sabha Elections 2024. #AkhileshYadav #Mainpuri #UttarPradesh #LokSabhaElections #LokSabhaElections2024 #Elections2024 #Mainpuri #MainpuriElections #SamajwadiParty #AkhileshYadavExclusive #Oneindia ~PR.274~GR.125~HT.98~

Credit: Oneindia Duration: 02:44Published now